Research programme: estrogen receptor-beta-selective agonists - Radius
Latest Information Update: 07 Mar 2008
Price : $50
At a glance
- Originator University of Illinois
- Developer Radius Health Inc.
- Mechanism of Action Selective estrogen receptor beta agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Preclinical Endometriosis; Inflammation
Most Recent Events
- 07 Mar 2008 This programme is still in active development
- 10 Aug 2006 Preclinical trials in Endometriosis in USA (unspecified route)
- 10 Aug 2006 Preclinical trials in Inflammation in USA (unspecified route)